Synapse: Law for Life Sciences

 

 

 

 

Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Asset-Centric Special Purpose Vehicles
Promoting medicines
Genesis 2014
Subscribe to Synapse

This month on Synapse: Asset-Centric special purpose vehicles (SPVs)

 

Asset-centric SPVs can prove to be a mechanism by which to develop and manage an IP-rich asset over a short period for a profit. In this month's lead article, Daniel Rooke examines the benefits and disadvantages in using Asset-Centric SPVs and the procedural steps behind setting one up.

 

 

arrowView our previous articles

Topical Issues

 

EMA policy on publication of clinical trial data

Diana Heimhalt provides an update in respect of the EMA's decision to agree a policy on the publication of clinical trial data... read more

 

 

Infringement of second medical use claims in Germany

Anja Lunze provides insight into infringement of second medical use claims and an overview of the current debate surrounding the issue in Germany... read more

Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...
Register here